← Leaderboards
Zheng-Zheng Shi
Methodist Hospital Research Institute
$1,584,275
Attributed
$1,584,275
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $322.7K · FY2011–15$500K$375K$250K$125K$0
'11
'12
'13
'14
'15
Funding mix
By agency
NIH$1,584,275 · 1
By mechanism
R01$1,584,275 · 1
Top collaborators
No co-investigators on record.
Most similar at Methodist Hospital Research Institute
Same institution · by research overlap
- Dan Theodorescu$43,145,134
- Stephen Tc Wong$23,111,474
- Shu-Hsia Chen$16,255,143
- Qing Yi$20,966,577
- Henry J. Pownall$10,844,928
Others in their field
Top investigators on “Adverse Effects”
- James Dennis Neaton · Northwestern University$203,539,316
- John M Lachin · George Washington University$139,991,329
- Elizabeth A Thom · George Washington University$126,101,581
- David M Nathan · Massachusetts Institute Of Technology$120,651,895
- Constance Ann Benson · University Of California, San Diego$114,806,215
- Wafaa M. El-Sadr · Columbia University Health Sciences$102,102,044
Research focus
Adverse EffectsActinsAnimal ModelAnoikisAffectAtp PhosphohydrolaseBaseBinding (Molecular Function)BiochemicalBiologicalBreast Cancer CellAntioxidantsCancer CellCause Of DeathCell DeathCell MotilityCellsCellular Stress ResponseCessation Of LifeChronic DiseaseComplexDevelopmental BiologyDisseminated Malignant NeoplasmDrug Discovery
Grant awards (5)
Inhibition of OLA1: A Novel Strategy for Anti-Metastasis Therapy$322,663
R01 · FY2015 · CA · contact PI
Inhibition of OLA1: A Novel Strategy for Anti-Metastasis Therapy$312,983
R01 · FY2014 · CA · contact PI
Inhibition of OLA1: a novel strategy for anti-metastasis therapy$303,303
R01 · FY2013 · CA · contact PI
Inhibition of OLA1: a novel strategy for anti-metastasis therapy$322,663
R01 · FY2012 · CA · contact PI
Inhibition of OLA1: a novel strategy for anti-metastasis therapy$322,663
R01 · FY2011 · CA · contact PI